White House Outlines Dire Outcomes if Congress Fails to Pass COVID Relief Aid Bill 

March 15, 2022 by Alexa Hornbeck
White House Outlines Dire Outcomes if Congress Fails to Pass COVID Relief Aid Bill 

WASHINGTON — The White House issued a letter to House Speaker Nancy Pelosi on Tuesday outlining what might happen now that the $22.5 billion in COVID-19 relief aid was dropped from the Consolidated Appropriations Act of 2022.

“We continue to urge Congress to promptly provide the critical funds needed to prevent severe disruptions to our COVID response,” writes Shalanda Young, acting director of the Office of Management and Budget, and Jeffrey Zients, White House coordinator for COVID-19 response, in the letter.

“Waiting to provide funding until we’re in a surge will be too late.”

According to the letter, the exclusion of COVID-19 aid from the omnibus spending package could lead to no additional purchases of monoclonal antibodies sent to states, fewer tests made in America, fewer treatments for the immune compromised and a risk of running short on vaccines. 


According to the letter, the federal government initially planned an order of more monoclonal antibody treatments for March 25, but without additional funding this order will not be possible. 

The government will instead have to stretch the current supply of these treatments starting next week and will be forced to cut state allocations of the limited existing supply of monoclonal antibody treatments by more than 30%.

The letter indicates that without the funds from the omnibus spending bill there will also not be adequate resources to purchase enough booster vaccine doses for all Americans. 

Providers will no longer be able to submit claims for testing, treatments and vaccinating the uninsured — as the fund that reimburses doctors and other medical providers for caring for the uninsured will be scaled back this month and end completely in April.

The letter further states that starting March 22, the Uninsured Program will stop accepting new claims for testing and treatment due to lack of sufficient funds. Providers will no longer be able to submit claims for providing these services to uninsured individuals, this will force providers to either absorb these costs or turn away people who are uninsured. 

On April 5, the Uninsured Program will also stop accepting vaccination claims due to lack of sufficient funds.

The government had additional plans to purchase preventive treatments for those who are immunocompromised as soon as March 31, according to the letter. The deliveries of those treatments were set to start in September but that purchase will now be scaled back due to the lack of funding.


The president’s National COVID-19 Preparedness Plan outlined funding for an additional 20 million oral antiviral pills and accelerating the creation of the next generation of a pan–COVID-19 vaccine to provide a broader range of protection against a range of COVID-19 variants. The plan intended to maintain the domestic testing capacity beyond June. None of these actions will be possible without the funding, according to the letter.

The letter suggests that the Biden administration will also need to wind down some of the COVID-19 surveillance investments that may make the U.S. less able to detect the next variant, due to the absence of funding to immediately assess lab-based efficacy and real-world effectiveness of existing vaccines and treatments as new variants emerge.

The lack of funding might also damage global vaccination and treatment efforts, as the letter indicates that the administration would be unable to extend the Global VAX surge support to an additional 20+ under-vaccinated countries. 

The letter indicates that the U.S. Agency for International Development will be unable to provide supplies, tests, therapeutics, oxygen and humanitarian aid to countries still struggling to manage a continuing COVID-19 disease burden. 

The $1.5 trillion omnibus spending package passed Congress but without the large chunk of COVID-19 relief emergency aid — a package totaling $15.6 billion at the time it was cut — intended to fund vaccines, research and treatments for future pandemic threats. 

The trillions in funds, outlined in the almost 2,700-page document, will continue to fund federal government operations through the remainder of fiscal year 2022. 

Congress had initially requested around $22.5 billion in COVID-19 relief aid to be included in the package but that amount was eventually lowered to $15.6 billion.

Even with a lowered price tag on the COVID-19 relief aid, it still wasn’t enough to achieve full support from both parties. To reach a timely compromise, the COVID-19 relief funds were dropped during the final negotiations.

After the Senate vote, the White House Press Secretary Jen Psaki said in a statement that the administration will continue to “call on Congress to provide the funds urgently needed to prevent severe disruptions to our COVID response.” 


The House has been working up a separate bill aimed at getting the COVID-19 funding but any potential proposal is not expected to receive Senate support. 

Alexa Hornbeck can be reached at [email protected] 

A+
a-

In The News

Health

Voting

Health

June 29, 2022
by Alexa Hornbeck
White House Blueprint Tackles Maternal Health Crisis 

The White House has new plans to address maternal mortality through the Blueprint for Addressing the Maternal Health Crisis, an effort... Read More

The White House has new plans to address maternal mortality through the Blueprint for Addressing the Maternal Health Crisis, an effort to increase access and coverage for certain maternal health services, including behavioral health. The blueprint outlines five priorities to improve maternal health and outcomes: increasing access... Read More

June 29, 2022
by Alexa Hornbeck
FDA Advisors Lean Into Modifying COVID-19 Vaccines to Be Omicron-Specific

Key advisors from the U.S. Food and Drug Administration met on Tuesday to examine COVID-19 vaccines and whether there is need for... Read More

Key advisors from the U.S. Food and Drug Administration met on Tuesday to examine COVID-19 vaccines and whether there is need for modification as protection wanes. During the Vaccines and Related Biological Products Advisory Committee meeting, a majority of the panel, 19-2, ruled in favor of manufacturing an... Read More

June 29, 2022
by Alexa Hornbeck
Restoring Hope for Mental Health and Well-Being Act of 2022 Sails Through House

The Restoring Hope for Mental Health and Well-Being Act of 2022 was passed by the House on June 22 to tackle mental... Read More

The Restoring Hope for Mental Health and Well-Being Act of 2022 was passed by the House on June 22 to tackle mental illness and substance use disorder in the country, especially for rural and low-income communities.  The act passed the House with a vote of 402-20, and reauthorizes... Read More

June 29, 2022
by Alexa Hornbeck
Equity and Accountability Act Addresses Health Disparities

Sens. Cory Booker, D-N.J., and Raphael Warnock, D-Ga., have provided a roadmap for eliminating racial and ethnic health inequities. The senators’... Read More

Sens. Cory Booker, D-N.J., and Raphael Warnock, D-Ga., have provided a roadmap for eliminating racial and ethnic health inequities. The senators’ new legislation is called the Health Equity and Accountability Act, and they released it on June 24. The bill lays out 10 provisions and additional investments Congress... Read More

June 29, 2022
by Alexa Hornbeck
WHO Members Express Continued Concerns Over COVID and Monkeypox 

World Health Organization Director-General Tedros Adhanom Ghebreyesus called Wednesday for accelerated efforts to develop a pan-coronavirus vaccine. He said that while... Read More

World Health Organization Director-General Tedros Adhanom Ghebreyesus called Wednesday for accelerated efforts to develop a pan-coronavirus vaccine. He said that while honing vaccines to the evolving virus variants makes sense, he is concerned that the pace of mutation means the world is continuing to play catch up. ... Read More

June 29, 2022
by Alexa Hornbeck
NIH-Funded Study Reveals Evolutionary Tricks Tied to Health Longevity

National Institutes of Health-funded research released on June 23 offers new insights into why aging rates vary when it comes to evolutionary... Read More

National Institutes of Health-funded research released on June 23 offers new insights into why aging rates vary when it comes to evolutionary tricks, such as having armor and venom. The research was led by Ronald Kohanski, who serves as a director of the National Institute on Aging at... Read More

News From The Well
scroll top